[TNXP] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
13-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -17.61%
YoY- -15.33%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 3,989 0 33,902 0 9,739 9,027 0 -
PBT -27,975 -28,356 -33,005 -31,680 -28,981 -23,140 -26,417 3.89%
Tax -1,216 29,002 -1,790 5,611 -610 -196 -19 1495.95%
NP -27,975 -28,356 -33,005 -34,084 -28,981 -27,395 -26,417 3.89%
Tax Rate - - - - - - - -
Total Cost 31,964 28,356 66,907 34,084 38,720 36,422 26,417 13.53%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -701.30 0.00 -100.00 0.00 -291.31 -254.17 0.00 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -58.40 -85.71 -102.85 -111.06 -135.52 -244.55 -321.28 -67.87%
EPS Diluted -58.40 -85.71 -102.85 -111.06 -135.52 -244.55 -321.28 -67.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.